Cited 0 time in
Thromboembolic events identified during diagnosis of germ cell tumors in 2 children
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Oh, Hea-Lin | - |
| dc.contributor.author | Kang, Hae-Ryong | - |
| dc.contributor.author | Jeon, Seok-Cheol | - |
| dc.contributor.author | Lee, Young-Ho | - |
| dc.date.accessioned | 2022-07-16T14:03:42Z | - |
| dc.date.available | 2022-07-16T14:03:42Z | - |
| dc.date.issued | 2012-09 | - |
| dc.identifier.issn | 2092-9129 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/164855 | - |
| dc.description.abstract | We describe 2 cases in which radiographic evidence of thromboembolic events was obtained during germ cell tumor diagnosis. There was no evidence of coagulation factor abnormalities or contributory procedures or drugs in either patient. We used anticoagulation therapy for thrombolysis in one patient, but in the other, the thromboembolism resolved spontaneously. ? 2012 Korean Society of Hematology. | - |
| dc.format.extent | 4 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Korean Society of Hematology | - |
| dc.title | Thromboembolic events identified during diagnosis of germ cell tumors in 2 children | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.5045/kjh.2012.47.3.233 | - |
| dc.identifier.scopusid | 2-s2.0-84874028171 | - |
| dc.identifier.bibliographicCitation | 대한혈액학회지, v.47, no.3, pp 233 - 236 | - |
| dc.citation.title | 대한혈액학회지 | - |
| dc.citation.volume | 47 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 233 | - |
| dc.citation.endPage | 236 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART001698290 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordPlus | bleomycin | - |
| dc.subject.keywordPlus | carboplatin | - |
| dc.subject.keywordPlus | cisplatin | - |
| dc.subject.keywordPlus | cyclophosphamide | - |
| dc.subject.keywordPlus | etoposide | - |
| dc.subject.keywordPlus | protein C | - |
| dc.subject.keywordPlus | protein S | - |
| dc.subject.keywordPlus | warfarin | - |
| dc.subject.keywordPlus | adolescent | - |
| dc.subject.keywordPlus | anticoagulant therapy | - |
| dc.subject.keywordPlus | article | - |
| dc.subject.keywordPlus | body mass | - |
| dc.subject.keywordPlus | cancer combination chemotherapy | - |
| dc.subject.keywordPlus | case report | - |
| dc.subject.keywordPlus | child | - |
| dc.subject.keywordPlus | childhood disease | - |
| dc.subject.keywordPlus | computer assisted tomography | - |
| dc.subject.keywordPlus | Doppler echography | - |
| dc.subject.keywordPlus | female | - |
| dc.subject.keywordPlus | follow up | - |
| dc.subject.keywordPlus | germ cell tumor | - |
| dc.subject.keywordPlus | human | - |
| dc.subject.keywordPlus | hypopituitarism | - |
| dc.subject.keywordPlus | international normalized ratio | - |
| dc.subject.keywordPlus | myalgia | - |
| dc.subject.keywordPlus | nuclear magnetic resonance imaging | - |
| dc.subject.keywordPlus | partial thromboplastin time | - |
| dc.subject.keywordPlus | positron emission tomography | - |
| dc.subject.keywordPlus | postoperative period | - |
| dc.subject.keywordPlus | prothrombin time | - |
| dc.subject.keywordPlus | salpingooophorectomy | - |
| dc.subject.keywordPlus | school child | - |
| dc.subject.keywordPlus | thromboembolism | - |
| dc.subject.keywordAuthor | Chemotherapy | - |
| dc.subject.keywordAuthor | Germ cell tumor | - |
| dc.subject.keywordAuthor | Thromboembolism | - |
| dc.identifier.url | https://synapse.koreamed.org/articles/1033029 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
